🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary trial objective in this single arm trial is to assess the safety an...
Status
Completed
Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Start Date
2009-04
Trial ID
NCT00879866
Treatments Being Tested
The goal of this clinical research study is to learn if temozolomide alone ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00525031
Treatments Being Tested
The purpose of this study is to compare the free time to disease progressio...
Status
Completed
Location
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Start Date
2006-07
Trial ID
NCT00335595
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
The purpose of the study is to determine the effect of food with various am...
Status
Completed
Location
LABiomedical Research Institute at Harbor-UCLA Medical Center
Start Date
2009-07
Trial ID
NCT00924612
Treatments Being Tested
The purpose of this study is to examine how effective rituximab or tocilizu...
Status
Active Not Recruiting
Location
Johns Hopkins
Start Date
2020-09-25
Trial ID
NCT04375228
Treatments Being Tested
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-05
Trial ID
NCT00003428
Treatments Being Tested
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
The objective of the present trial is: * to determine the dose limiting to...
Status
Withdrawn
Location
Gustave Roussy Institute,
Start Date
2012-06
Trial ID
NCT01764009
Treatments Being Tested